Triple-Negative Breast Cancer 14 Dec 2025 · 3 min read Breakthrough Antibody Targeting SFRP2 Protein Halts Aggressive Breast Cancer in Preclinical Models Researchers at MUSC Hollings Cancer Center have developed a humanized antibody that neutralizes a key protein driving tumor growth and metastasis in triple-negative breast cancer. Read more